Browsing by Subject "bone density conservation agent"
Now showing items 1-1 of 1
-
Letter to the editor: From Min Gong et al: "Risk for infections during treatment with denosumab for osteoporosis: a systematic review and meta-analysis"
( Endocrine Society , 2020 , Other)To the editor: We read with great interest the systematic review by Diker-Cohen et al (1) about the risk of infection under the treatment of denosumab for osteoporosis. This is a well-conducted systematic review that ...